These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 22143525)
1. Resistance to linezolid caused by modifications at its binding site on the ribosome. Long KS; Vester B Antimicrob Agents Chemother; 2012 Feb; 56(2):603-12. PubMed ID: 22143525 [TBL] [Abstract][Full Text] [Related]
2. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233 [TBL] [Abstract][Full Text] [Related]
3. R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance. Skripkin E; McConnell TS; DeVito J; Lawrence L; Ippolito JA; Duffy EM; Sutcliffe J; Franceschi F Antimicrob Agents Chemother; 2008 Oct; 52(10):3550-7. PubMed ID: 18663023 [TBL] [Abstract][Full Text] [Related]
5. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Toh SM; Xiong L; Arias CA; Villegas MV; Lolans K; Quinn J; Mankin AS Mol Microbiol; 2007 Jun; 64(6):1506-14. PubMed ID: 17555436 [TBL] [Abstract][Full Text] [Related]
6. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms. Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167 [TBL] [Abstract][Full Text] [Related]
7. Mutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance. Long KS; Munck C; Andersen TM; Schaub MA; Hobbie SN; Böttger EC; Vester B Antimicrob Agents Chemother; 2010 Nov; 54(11):4705-13. PubMed ID: 20696869 [TBL] [Abstract][Full Text] [Related]
8. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. Kloss P; Xiong L; Shinabarger DL; Mankin AS J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031 [TBL] [Abstract][Full Text] [Related]
9. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Mendes RE; Deshpande LM; Jones RN Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801 [TBL] [Abstract][Full Text] [Related]
10. Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations. de Almeida LM; de Araújo MR; Sacramento AG; Pavez M; de Souza AG; Rodrigues F; Gales AC; Lincopan N; Sampaio JL; Mamizuka EM Antimicrob Agents Chemother; 2013 Aug; 57(8):4082-3. PubMed ID: 23689714 [No Abstract] [Full Text] [Related]
11. Oxazolidinones: activity, mode of action, and mechanism of resistance. Bozdogan B; Appelbaum PC Int J Antimicrob Agents; 2004 Feb; 23(2):113-9. PubMed ID: 15013035 [TBL] [Abstract][Full Text] [Related]
12. Tedizolid for the management of human infections: in vitro characteristics. Locke JB; Zurenko GE; Shaw KJ; Bartizal K Clin Infect Dis; 2014 Jan; 58 Suppl 1():S35-42. PubMed ID: 24343830 [TBL] [Abstract][Full Text] [Related]
13. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Locke JB; Hilgers M; Shaw KJ Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277 [TBL] [Abstract][Full Text] [Related]
14. A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance. Rajan V; Kumar VG; Gopal S Indian J Med Res; 2014 Mar; 139(3):463-7. PubMed ID: 24820843 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of linezolid-resistant CoNS isolates in Japan. Takaya A; Kimura A; Sato Y; Ishiwada N; Watanabe M; Matsui M; Shibayama K; Yamamoto T J Antimicrob Chemother; 2015 Mar; 70(3):658-63. PubMed ID: 25381168 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China. Tian Y; Li T; Zhu Y; Wang B; Zou X; Li M BMC Microbiol; 2014 Nov; 14():292. PubMed ID: 25420718 [TBL] [Abstract][Full Text] [Related]
18. Resistance to linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: novel mutation in domain V of 23S rRNA. Musumeci R; Calaresu E; Gerosa J; Oggioni D; Bramati S; Morelli P; Mura I; Piana A; Are BM; Cocuzza CE New Microbiol; 2016 Oct; 39(4):269-273. PubMed ID: 27727405 [TBL] [Abstract][Full Text] [Related]
19. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Locke JB; Hilgers M; Shaw KJ Antimicrob Agents Chemother; 2009 Dec; 53(12):5275-8. PubMed ID: 19805557 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations. Locke JB; Finn J; Hilgers M; Morales G; Rahawi S; G C K; Picazo JJ; Im W; Shaw KJ; Stein JL Antimicrob Agents Chemother; 2010 Dec; 54(12):5337-43. PubMed ID: 20837751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]